Compare TOVX & RS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TOVX | RS |
|---|---|---|
| Founded | 2001 | 1939 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3M | 14.9B |
| IPO Year | 2006 | 1994 |
| Metric | TOVX | RS |
|---|---|---|
| Price | $0.18 | $290.03 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 4 |
| Target Price | N/A | ★ $317.25 |
| AVG Volume (30 Days) | ★ 2.8M | 338.6K |
| Earning Date | 11-12-2025 | 10-22-2025 |
| Dividend Yield | N/A | ★ 1.62% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 13.63 |
| Revenue | N/A | ★ $13,922,300,000.00 |
| Revenue This Year | N/A | $5.75 |
| Revenue Next Year | N/A | $4.42 |
| P/E Ratio | ★ N/A | $21.76 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.17 | $250.07 |
| 52 Week High | $2.08 | $347.44 |
| Indicator | TOVX | RS |
|---|---|---|
| Relative Strength Index (RSI) | 38.44 | 56.21 |
| Support Level | $0.17 | $284.91 |
| Resistance Level | $0.24 | $300.72 |
| Average True Range (ATR) | 0.02 | 6.51 |
| MACD | -0.00 | 0.89 |
| Stochastic Oscillator | 23.04 | 57.83 |
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
Reliance Inc is a diversified metal solutions provider and metals service center company. It provides value-added metals processing services and distributes.